Trial intelligence / Profile preview

Hydrogen gas inhalation to relieve acute toxicities from concurrent chemoradiotherapy in locally advanced head and neck cancer

TCTR20230627002Phase 2Unknown

Sponsor
Faculty of Medicine, Chiang Mai University
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Molecular hydrogen in head and neck cancer (HNC), sponsored by Faculty of Medicine, Chiang Mai University. Status: unknown.

02

Drugs

Molecular hydrogen
03

Conditions

head and neck cancer (HNC)

Beyond the preview

Go deeper on TCTR20230627002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230627002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call